Fingolimod (INN, trade name Gilenya, Novartis) is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). It has reduced the rate of relapses in relapsing-remitting multiple sclerosis by approximately one-half over a two-year period. Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.

CAS：162359-55-9
中文别名：
英文别名：2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;Fingolimod;UNII-3QN8BYN5QF;
分子式：C19H33NO2
分子量：307.471
精确质量：307.251
Psa：66.48
Logp：3.9046

UNII：3QN8BYN5QF

密度：1.016
沸点：479.5ºC at 760 mmHg
闪点：243.8ºC